TickerFacts.

Enovis Corp (ENOV): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$36.39M
As of 2025-12-31
$12.56M
As of 2026-07-03
+14.4%
3-year compound annual growth
$680.25M2009-12-31: $49.96M2010-12-31: $60.54M2011-04-01: $45.46M2011-09-30: $64.45M2011-12-31: $75.11M2012-12-31: $482.45M2013-12-31: $311.30M2014-12-31: $305.45M2015-12-31: $197.47M2016-12-31: $208.81M2017-12-31: $262.02M2018-12-31: $77.15M2019-12-31: $109.63M2020-12-31: $97.07M2021-12-31: $680.25M2022-12-31: $24.30M2023-12-31: $36.19M2024-12-31: $48.17M2025-12-31: $36.39M$36.39M
2009-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$36.39M-24.5%2026-02-26, Balance as of period end
2024-12-31$48.17M+33.1%2026-02-26, Balance as of period end
2023-12-31$36.19M+49.0%2026-02-26, Balance as of period end
2022-12-31$24.30M-96.4%2024-02-22, Balance as of period end
2021-12-31$680.25Mn/c2023-03-01, Balance as of period end
2020-12-31$97.07M-11.5%2022-02-22, Balance as of period end
2019-12-31$109.63M+42.1%2021-02-18, Balance as of period end
2018-12-31$77.15M-70.6%2020-02-24, Balance as of period end
2017-12-31$262.02M+25.5%2019-02-21, Balance as of period end
2016-12-31$208.81Mn/c2018-02-16, Balance as of period end
2015-12-31$197.47M-35.4%2017-02-14, Balance as of period end
2014-12-31$305.45M-1.9%2017-02-14, Balance as of period end
2013-12-31$311.30M-35.5%2016-02-16, Balance as of period end
2012-12-31$482.45M+542.3%2015-02-17, Balance as of period end
2011-12-31$75.11Mn/a2014-02-12, Balance as of period end
2011-09-30$64.45Mn/a2013-02-19, Balance as of period end
2011-04-01$45.46Mn/a2013-02-19, Balance as of period end
2010-12-31$60.54M+21.2%2013-02-19, Balance as of period end
2009-12-31$49.96Mn/a2012-02-23, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Enovis Corp (ENOV)2025-12-31$36.39M-24.5%
MSA Safety Inc (MSA)2025-12-31$165.07M+0.3%
Align Technology Inc (ALGN)2025-12-31$1.09B+4.9%
Edwards Lifesciences Corp (EW)2025-12-31$2.94B-3.5%
Zimmer Biomet Holdings, Inc. (ZBH)2025-12-31$591.90M+12.6%
Cadre Holdings, Inc. (CDRE)2025-12-31$122.90M-1.6%
Intuitive Surgical Inc (ISRG)2025-12-31$3.37B+66.1%
Inogen Inc (INGN)2025-12-31$103.73M-8.8%
Establishment Labs Holdings Inc. (ESTA)2025-12-31$75.57M-16.4%

Compare ENOV, MSA, ALGN, EW side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗